Back to results
US 4,228,176 AGranted
Thromboxane inhibition with burimamide
AssigneeNelson Research & Development Company
InventorsKenneth E. Eakins, Geoffrey Allan
Life of this patent
Estimating the term…
Abstract
The disclosure describes a method for selectively inhibiting thromboxane biosynthesis with Burimamide, a compound previously known to be a histamine H.sub.2 -receptor blocker. The discovery is useful in the treatment of a number of cardiovascular and inflammatory diseases in which thromboxane biosynthesis is involved.
Claims7
A method for treatment of an imflammatory disease condition comprising the administration to a human or animal suffering from an inflammatory disease condition of an effective, anti-inflammatory amount of Burimamide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.